Literature DB >> 20545765

Extracellular domain dependence of PTPalpha transforming activity.

Barbara Tremper-Wells1, Ross J Resnick1, Xinmin Zheng1, Leslie J Holsinger2, David Shalloway1.   

Abstract

Two isoforms of the transmembrane protein tyrosine phosphatase PTPalpha, which differ by nine amino acids in their extracellular regions, are expressed in a tissue-specific manner. Over-expression of the shorter isoform transforms rodent cells, and it has previously been reasonable to assume that this was a direct consequence of its dephosphorylation and activation of Src. Transformation by the longer wild-type isoform has not previously been studied. We tested the activities of both isoforms in NIH3T3 cells and found that, while both dephosphorylated and activated Src similarly, only the shorter isoform induced focus formation or anchorage-independent growth. Differences in phosphorylation of PTPalpha at its known regulatory sites, Grb2 binding to PTPalpha, phosphorylation level of focal adhesion kinase by PTPalpha, or overall localization were excluded as possible explanations for the differences in transforming activities. The results suggest that transformation by PTPalpha involves at least one function other than, or in addition to, its activation of Src and that this depends on PTPalpha's extracellular domain. Previous studies have suggested that PTPalpha might be a useful target in breast and colon cancer therapy, and the results presented here suggest that it may be advantageous to develop isoform-specific therapeutic reagents.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20545765      PMCID: PMC4876864          DOI: 10.1111/j.1365-2443.2010.01410.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  57 in total

Review 1.  CD45: a critical regulator of signaling thresholds in immune cells.

Authors:  Michelle L Hermiston; Zheng Xu; Arthur Weiss
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  Extracellular domain splice variants of a transforming protein tyrosine phosphatase alpha mutant differentially activate Src-kinase dependent focus formation.

Authors:  Katja Kapp; Jan Siemens; Peter Weyrich; Jörg B Schulz; Hans-Ulrich Häring; Reiner Lammers
Journal:  Genes Cells       Date:  2007-01       Impact factor: 1.891

Review 3.  Mechanisms of focal adhesion kinase regulation.

Authors:  Lee Ann Cohen; Jun-Lin Guan
Journal:  Curr Cancer Drug Targets       Date:  2005-12       Impact factor: 3.428

4.  Expression of protein-tyrosine phosphatases in the major insulin target tissues.

Authors:  K Norris; F Norris; D H Kono; H Vestergaard; O Pedersen; A N Theofilopoulos; N P Møller
Journal:  FEBS Lett       Date:  1997-10-06       Impact factor: 4.124

5.  Stimulation of receptor protein-tyrosine phosphatase alpha activity and phosphorylation by phorbol ester.

Authors:  J den Hertog; J Sap; C E Pals; J Schlessinger; W Kruijer
Journal:  Cell Growth Differ       Date:  1995-03

6.  The location of v-src in a retrovirus vector determines whether the virus is toxic or transforming.

Authors:  W G Tarpley; H M Temin
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

7.  Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts.

Authors:  J Su; M Muranjan; J Sap
Journal:  Curr Biol       Date:  1999-05-20       Impact factor: 10.834

8.  Identification of p130cas as an in vivo substrate of receptor protein-tyrosine phosphatase alpha.

Authors:  A Buist; C Blanchetot; L G Tertoolen; J den Hertog
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

9.  A phosphotyrosine displacement mechanism for activation of Src by PTPalpha.

Authors:  X M Zheng; R J Resnick; D Shalloway
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

10.  Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation.

Authors:  T E Kmiecik; D Shalloway
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

View more
  5 in total

1.  Loss of function studies in mice and genetic association link receptor protein tyrosine phosphatase α to schizophrenia.

Authors:  Nagahide Takahashi; Karin Sandager Nielsen; Branko Aleksic; Steffen Petersen; Masashi Ikeda; Itaru Kushima; Nathalie Vacaresse; Hiroshi Ujike; Nakao Iwata; Véronique Dubreuil; Naheed Mirza; Takeshi Sakurai; Norio Ozaki; Joseph D Buxbaum; Jan Sap
Journal:  Biol Psychiatry       Date:  2011-08-10       Impact factor: 13.382

2.  Vascular endothelial growth factor (VEGF) and platelet (PF-4) factor 4 inputs modulate human microvascular endothelial signaling in a three-dimensional matrix migration context.

Authors:  Ta-Chun Hang; Nathan C Tedford; Raven J Reddy; Tharathorn Rimchala; Alan Wells; Forest M White; Roger D Kamm; Douglas A Lauffenburger
Journal:  Mol Cell Proteomics       Date:  2013-09-09       Impact factor: 5.911

3.  Increased PTPRA expression leads to poor prognosis through c-Src activation and G1 phase progression in squamous cell lung cancer.

Authors:  Zhidong Gu; Xuqian Fang; Chang Li; Changqiang Chen; Guangshu Liang; Xinming Zheng; Qishi Fan
Journal:  Int J Oncol       Date:  2017-06-23       Impact factor: 5.650

4.  PTPRA Phosphatase Regulates GDNF-Dependent RET Signaling and Inhibits the RET Mutant MEN2A Oncogenic Potential.

Authors:  Leena Yadav; Elina Pietilä; Tiina Öhman; Xiaonan Liu; Arun K Mahato; Yulia Sidorova; Kaisa Lehti; Mart Saarma; Markku Varjosalo
Journal:  iScience       Date:  2020-01-31

5.  PTPRA facilitates cancer growth and migration via the TNF-α-mediated PTPRA-NF-κB pathway in MCF-7 breast cancer cells.

Authors:  Canfeng Lin; Shubo Xin; Xiaoguang Huang; Feiran Zhang
Journal:  Oncol Lett       Date:  2020-08-20       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.